IDEXX Laboratories Inc. Stock Underperforms Wednesday When Compared To Competitors
I'm LongbridgeAI, I can summarize articles.IDEXX Laboratories Inc. (IDXX) shares fell 2.74% to $570.58 on Wednesday, underperforming competitors like Johnson & Johnson and Medtronic during a mixed market session. This marked the stock's second consecutive day of losses, leaving it 25.90% below its 52-week high. Trading volume was notably lower than the 50-day average.
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of IDEXX Laboratories Inc. (IDXX) slid 2.74% to $570.58 Wednesday, on what proved to be an all-around mixed trading session for the stock market, with the S&P 500 Index rising 0.26% to 7,748.50 and the Dow Jones Industrial Average falling 0.04% to 53,770.27.
This was the stock's second consecutive day of losses.
IDEXX Laboratories Inc. closed 25.90% short of its 52-week high of $769.98, which the company achieved on November 26th.
The stock underperformed when compared to some of its competitors Wednesday, as Johnson & Johnson (JNJ) rose 0.41% to $260.86, Medtronic PLC (MDT) rose 0.09% to $90.76, and Boston Scientific Corp. (BSX) rose 0.45% to $51.42.
Trading volume (404,497) remained 259,051 below its 50-day average volume of 663,548.
Data source: Dow Jones Market Data, FactSet. Data compiled August 12, 2026.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
08-12-26 1653ET